Drug intelligence / Profile preview

Earwax MD

Development stage
Unknown
Lead developer
EOSERA
Modality
Small Molecules
Administration
Topical
01

Overview

**Earwax MD** is a patented, over-the-counter topical ear drop formulation developed by Eosera, a Dallas-based biotechnology company, for the removal of excessive or impacted earwax (cerumen). It employs a proprietary **dual-action technology** that disrupts the lipid and wax components of earwax using sodium and potassium bicarbonates to convert hydrophobic fatty acids into hydrophilic forms, while glycolic acid loosens attached skin cells (keratinocytes) and debris; glycerin provides hyper-hydration to facilitate breakdown. Clinically proven in a study of 30 impacted ears to fully clear impaction in 86% of cases with 1-2 applications in 15-30 minutes and reduce symptoms (fullness, itching, hearing loss) by 82%, it outperforms competitors like Debrox and Murine in lab tests on human earwax disintegration. Safe for ages 2+, dermatologist-tested with no reported irritation, and available in kits with rinsing bulbs; made in the USA.[1][2][3][5][6]

Brand names
Earwax MD
Other names
eosera EAR WAX MDEAR WAX MD

Beyond the preview

Go deeper on Earwax MD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Earwax MD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call